An experimental depression drug that joined the Neurocrine Biosciences pipeline as part of a broader package from Takeda Pharmaceutical failed to meet the main goal of a mid-stage clinical trial. The ...

Add Yahoo as a preferred source to see more of our stories on Google. Stock photo from Getty Images. The Ohio Board of Pharmacy on Tuesday suspended the license of a beauty spa after determining that ...